Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
On Sample Size Determination of Bioequivalence Trials
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 박상규 | - |
| dc.date.available | 2019-07-24T03:04:42Z | - |
| dc.date.issued | 2007-06 | - |
| dc.identifier.issn | 1598-9402 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/30048 | - |
| dc.description.abstract | Sample size determination plays an important role in designing a bioequivalence trial. Formulae of sample sizes based on Schuirmann's two one-sided tests procedures are given for bioequivalence studies with the 2x2 crossover design and two-sample parallel design. A practical discussion for the relationship among these formulae is given. | - |
| dc.format.extent | 9 | - |
| dc.language | 한국어 | - |
| dc.language.iso | KOR | - |
| dc.publisher | 한국데이터정보과학회 | - |
| dc.title | On Sample Size Determination of Bioequivalence Trials | - |
| dc.type | Article | - |
| dc.identifier.bibliographicCitation | 한국데이터정보과학회지, v.18, no.2, pp 365 - 373 | - |
| dc.identifier.kciid | ART001064805 | - |
| dc.description.isOpenAccess | N | - |
| dc.citation.endPage | 373 | - |
| dc.citation.number | 2 | - |
| dc.citation.startPage | 365 | - |
| dc.citation.title | 한국데이터정보과학회지 | - |
| dc.citation.volume | 18 | - |
| dc.identifier.url | https://www.dbpia.co.kr/journal/articleDetail?nodeId=NODE07244076 | - |
| dc.publisher.location | 대한민국 | - |
| dc.subject.keywordAuthor | Bioequivalence | - |
| dc.subject.keywordAuthor | Crossover Design | - |
| dc.subject.keywordAuthor | Inter-Variability | - |
| dc.subject.keywordAuthor | Intra-Variability | - |
| dc.subject.keywordAuthor | Parallel Design | - |
| dc.subject.keywordAuthor | Power | - |
| dc.subject.keywordAuthor | Sample Size | - |
| dc.description.journalRegisteredClass | kci | - |
- Files in This Item
- Go to Link
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.